Akpamuk, U. Et Al. 2022. The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey. ISPOR 2022 , (Washington, United States Of America), 193.

Akpamuk, U., Hughes, R., Swales, O., Oyan Uluç, B., Kılıçkap, S., Demirci, U., ... Sendur, M. A.(2022). The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey . ISPOR 2022 (pp.193). Washington, United States Of America

Akpamuk, Ugur Et Al. "The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey," ISPOR 2022, Washington, United States Of America, 2022

Akpamuk, Ugur Et Al. "The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey." ISPOR 2022 , Washington, United States Of America, pp.193, 2022

Akpamuk, U. Et Al. (2022) . "The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey." ISPOR 2022 , Washington, United States Of America, p.193.

@conferencepaper{conferencepaper, author={Ugur Akpamuk Et Al. }, title={The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey}, congress name={ISPOR 2022}, city={Washington}, country={United States Of America}, year={2022}, pages={193} }